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Highlights 
 Bipolar hemiarthroplasty is associated with greater range of motion and less 
acetabular erosion than unipolar hemiarthroplasty.  
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 The operative time was longer during bipolar hemiarthroplasty compared to 
unipolar hemiarthroplasty. 
 No significant difference in hip function using Harris hip score, mortality, surgical, 
and medical outcomes is evident. 
 
ABSTRACT 
Purpose: To assess the clinical outcomes of unipolar versus bipolar hemiarthroplasty for 
displaced intracapsular femoral neck fractures in older patients and to report whether 
bipolar implants yield better long-term functional results. 
Methods: We searched PubMed, Scopus, EBSCO, and Cochrane Library for relevant 
randomized clinical trials (RCTs) and observational studies, comparing unipolar and 
bipolar hemiarthroplasty. Data was extracted from eligible studies and pooled as relative 
risk (RR) or mean difference (MD) with corresponding 95% confidence intervals (CI) 
using RevMan software for Windows. 
Results: A total of 30 studies were included (13 RCTs and 17 observational studies). 
Analyses included 30250 patients with a mean age of 79 years and mean follow-up time of 
24.6 months. The overall pooled estimates showed that bipolar was superior to unipolar 
hemiarthroplasty in terms of hip function, range of motion and reoperation rate, but at the 
expense of longer operative time. In the longer term the unipolar group had higher rates of 
acetabular erosion compared to the to the bipolar group. There was no significant 
difference in terms of hip pain, implant related complications, intraoperative blood loss, 
mortality, six-minute walk times, medical outcomes, and hospital stay and subsequently 
cost.  
Conclusions: Bipolar hemiarthroplasty is associated with better range of motion, lower 
rates of acetabular erosion and lower reoperation rates compared to the unipolar 
hemiarthroplasty but at the expense of longer operative time. Both were similar in terms of 
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mortality, and surgical or medical outcomes. Future large studies are recommended to 
compare both methods regarding the quality of life. 
 
keywords: Unipolar; Bipolar; Hemiarthroplasty; hip; reoperation; acetabular erosion 
 
INTRODUCTION 
Displaced intra-articular femoral neck fractures are commonly encountered in geriatric 
population secondary to senile osteoporosis 1,2. The purported advantages of HA include 
earlier mobility, lower reoperation rates and better functional outcomes at 1 year 3.  
A substantial difference of opinion exists on the choice between unipolar and bipolar 
designs. The hypothetical advantage of the bipolar design over the unipolar one is the 
reduction of acetabular erosion attributed to motion occurring within the components rather 
than at the acetabular implant interface 4. Therefore, it is hypothesized that bipolar implants 
yield improved long-term functional results with reduced complications 5. However, 
evidence supporting this theory is scarce within the literature. 
The purpose of this meta-analysis is to assess the clinical outcomes and surgical 
complications of unipolar versus bipolar hemiarthroplasty for femoral neck fractures in 
older patients. 
MATERIALS AND METHODS  
All steps of this systematic review were performed in a strict accordance with the Cochrane 
handbook of systematic reviews and meta-analysis 6,7. Additionally, the preferred reporting 
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items for systematic reviews and meta-analyses (PRISMA statement guidelines) were 
followed the during drafting of the manuscript 8. 
Literature search strategy 
We searched PubMed, Scopus, EBSCO, Cochrane library, and web of science for articles 
published before May 1, 2017, using the following keywords: hemiarthroplasty, 
arthroplasty, displaced femoral neck fractures, hip fractures, hip prosthesis, hip 
replacement, unipolar, monopolar, bipolar. We also checked the clinical trial registry 
(Clinicaltrials.gov) for additional ongoing and unpublished studies. The reference lists of 
relevant reviews and articles were further scanned for additional relevant studies. 
Eligibility criteria 
Randomized clinical trials (RCTs) and observational studies that compared bipolar (BH) 
versus unipolar hemiarthroplasty (UH) in management of elderly patients with femoral 
neck fractures were included in our meta-analysis.  
We excluded non-English articles, reviews, case reports, duplicate references, and studies 
that included patients with immature skeleton, delayed union, nonunion, previous surgery, 
or pathological fractures. 
Selection process 
Three authors independently applied the selection criteria. Eligibility screening was 
conducted in two steps, a) titles and abstract screening for matching the inclusion criteria, 
and b) full text screening of eligibility for meta-analysis. Disagreements were resolved 
upon the result of discussion. 
Outcomes of interest  
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We included studies reporting at least one of the following outcomes: hip function 
postoperatively using modified Harris Hip Score 9,10, hip pain, reoperation rate, operative 
details (operative duration and intraoperative blood loss), mortality, implant related 
complications (e.g. periprosthetic fractures, dislocations of prosthesis, loosening of 
prosthesis and wound infection), quality of life, range of motion (flexion, adduction, 
abduction, internal rotation, and external rotation), 6-minute walk test, acetabular erosion, 
medical complications (e.g. pulmonary embolism, cardiac arrest, myocardial infarction, 
acute heart failure and deep venous thrombosis), length of hospital stay, and cost. 
Data Extraction 
Two reviewers independently extracted and tabulated data on first author, publication year, 
study design, number of participants in each group, mean age, gender, type of intervention, 
study period, follow up period and relevant outcomes data. Another reviewer resolved 
disagreements, and reasons of exclusion were recorded.  
Risk of bias assessment 
For clinical trials, two review authors independently used the Cochrane risk of bias (ROB) 
assessment tool, clearly described in (chapter 8.5) of the Cochrane handbook of systematic 
reviews of interventions 5.1.0 6. For observational studies, we used the Newcastle Ottawa 
scale (NOS) for assessing the quality of observational studies 11.  
Each included study was assessed based on reporting of three essential domains: a) 
selection of the study subjects, b) comparability of groups on demographic characteristics 
and important potential confounders, and c) ascertainment of the prespecified outcome 
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(exposure/treatment). To assess the risk of bias across included studies, we compared the 
reported outcomes between all studies to exclude selective reporting of outcomes.  
Dealing with missing data 
In cases of missing standard deviation (SD) data, SD was calculated from the 
corresponding standard error or confidence interval according to Altman 12. 
 
Data analysis 
For dichotomous data, we calculated relative risks (RR) and 95% confidence intervals (CI) 
for each outcome. For continuous data, we calculated mean difference (MD) and 95% 
confidence intervals (CI) for each outcome. The statistics analysis was conducted with 
Review Manager version 5.3 and Comprehensive meta-analysis software for windows. An 
alpha level of <0.05 was considered statistically significant. 
Assessment of Heterogeneity  
We tested for heterogeneity among included studies by the Chi-Square test and I-square 
tests. A p value of >0.1 and I-square value of <50% were considered as no statistical 
heterogeneity. We performed the meta-analysis using a fixed-effect model if no significant 
heterogeneity was present (I2<50 %; p>0.1). Otherwise we adopted the random effect 
model. 
Sensitivity analysis  
To resolve detected statistical heterogeneity, we performed sensitivity analysis excluding 
one study in each scenario.  
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Publication bias 
To investigate the possibility of publication bias, we used the Egger’s test 13 and the funnel 
plot method. In case of significant publication bias, the trim and fill method were used for 
correction and the effect estimate was recalculated accordingly. 
 
 
 
RESULTS 
Demographics and characteristics 
Our search yielded 174 unique citations. Thirty studies were selected for inclusion in our 
meta-analysis, of which 13 were RCTs and 17 were observational studies (Fig. 1). The 30 
included studies (table 1) included a total of 30250 participants with a mean age of 79 years 
and mean follow up 24.6 months. 15190 patients underwent bipolar HA and 15060 
underwent unipolar HA. Both groups had similar characteristics (table 2). 
Quality of evidence 
All RCTs were at low risk of bias regarding selective reporting and incomplete outcome 
data. Eight out of 13 RCTs achieved adequate random sequence generation, four trials 
described allocation concealment and eight kept unbroken blinding (Fig. 2a). 
Observational studies achieved a mean of 7 out of 9 points on the NOS indicating a 
moderate quality (fig. 2b). 
Outcomes (table 3) 
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Ten studies (7 RCTs 5,14-19 and 4 observational studies 20-23) reported data on postoperative 
hip function using Harris Hip score (HHS). The pooled estimate (figure 3) showed initial 
better score at 1 and 2 years (MD=2.30, 95% ]0.14, 4.47[, P=0.04; MD=2.68, 95% CI 
]0.98, 4.37[, P=0.002, respectively) and then no significant difference between the BH and 
UH groups at four years’ follow-up (MD=0.67, 95% CI ]-3.29, 4.63[, P=0.74; MD=2.61, 
95% CI ]-3.80, 9.02[, P=0.42, respectively). . 
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  Table 1: Summary of the included studies 
No. Authors 
Publication 
year 
Study type Study size 
Mean duration 
of follow-up 
Outcome measures 
1.  Abdelkhalek et al. 19 2011 RCT 50 4.4 (2-6) years 
Hip function, pain and ROM,  
Prosthesis migration, subsidence, loosening and dislocation 
LLD, acetabular erosion, conversion to THR. limping, infection, DVT 
2.  Ayhan et al. 21 2013 Observational 144 Minimum 1 year 
Quality of life, mortality, hip function, acetabular erosion, infection, 
DVT 
3.  Azhar MM 24 2015 Observational 44 2.3 (1-3) years 
Hip function, fracture of implant, dislocation of implant, acetabular 
erosion, acetabulum protusia, loosening, calcar resorption and 
osteolysis, hip pain, infection, sciatic nerve injury 
4.   Balan et al. 14 2016 RCT 68 One year 
Hip function, sciatic nerve palsy, stem subsidence, peri-prosthetic 
fracture, pneumonia, superficial infection and dislocation 
5.  Biščević and Smrke 23 2005 Observational 694 3.8 (2-8.6) years Hip function, hip pain, limping, ROM 
6.  Calder et al. 5 1996 RCT 250 1.7 (1-3) years 
Hip function, hip pain, limping, mortality, infection, dislocation, 
acetabular erosion, satisfaction, return to preinjury status  
7.  Cornell et al. 15 1998 RCT 48 6 months 
Hip function, ROM, prosthetic dislocation, 6-minute walk test, get up 
and go 
8.  Davison et al. 25 2001 RCT 280 Minimum 2 years 
Hip function, mortality, morbidity, revision surgery, satisfaction, return 
to preinjury status, acetabular erosion, subsidence, loosening, head 
migration 
9.  Enocson et al. 26 2011 Observational 830 3.1 (0–9.1) years 
Reoperation rate, dislocation, deep infection, periprosthetic fracture, 
acetabular erosion 
10.  Grosso et al. 27 2016 Observational 686 Minimum 2 years 
acetabular erosion, loosening, periprosthetic fracture, dislocation, 
revision surgery 
11.  Hudson et al. 2 1998 Observational 367 8 years Revision, mortality, surgical complications 
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12.  Inngul et al. 16 2013 RCT 120 4 years Quality of life, hip function, acetabular erosion 
13.  Jain et al. 20 2016 Observational 39 3 years 
Hip function, mortality, complications, length of stay, dislocation, 
loosening, foot drop 
14.  Jeffcote et al. 28 2010 RCT 52 2 years 
Head migration, hip function, 6-minute walk test, mortality, 
complications 
15.  Kanto et al. 29 2014 RCT 175 8 years 
Hip function, mortality, acetabular erosion, dislocation (implant and 
patient survival) 
16.  Kenzora et al. 30 1998 Observational 270 Minimum 2 years 
Hip function, length of hospital stay, medical complications, quality of 
life, dislocation, infection, revision surgery 
17.  Leonardsson et al 31 2012 Observational 23,509 1.5 year Reoperation, dislocation, infection, periprosthetic fracture 
18.  Lin et al. 32 2012 Observational 120 5 years Hip pain, dislocation, infection, comorbidities, mortality 
19.  Malhotraet al. 33 1995 RCT 68 9-47 months 
Hip pain, ROM, limping, dislocation, infection, acetabular erosion, 
subsidence, revision surgery 
20.  Marcus,et al. 34 1992 Observational 173 22 (12-46) months 
Hip pain, function, mortality, complications, dislocation, intra-
operative femoral fractures, acetabular erosion, reoperation 
21.  Mishra et al. 35 2013 RCT 40 1 year 
Hip pain, function, ROM, acetabular erosion, complications, LLD, 
mortality 
22.  Ong et al. 36 2002 Observational 281 Minimum 3 years 
Hip pain, function, return to preinjury status, ADL, dislocation, medical 
and wound complications, revision surgery 
23.  Paton and Hirst 37 1989 Observational 171 6 months – 4 years Dislocation 
24.  Raia et al. 38 2003 RCT 115 1 year 
Quality of life, hip function, blood loss, length of hospital stay, 
mortality rate, number of dislocations, postoperative complications, or 
ambulatory status 
25.  Sabnis and Brenkel 4 2011 Observational 707 4 months Complications, ability to walk, use of aid, mortality, pain 
26.  Somashekar et al. 17 2013 RCT 41 1 year 
Hip function, ROM, painful hip, posterior dislocation, periprosthetic 
fracture, acetabular erosion 
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27.  Stoffel et al. 18 2013 RCT 261 1 year 
Hip function, hip, pain, ROM, 6-minute-walk test, length of stay, 
infection, DVT, comorbidities 
28.  Wathne et al. 39 1995 Observational 140 Minimum 1 year 
Hip function, hip pain, comorbidities, length of stay, postoperative 
complications, mortality rate, revision surgery 
29.  Yamagata et al. 22 1987 Observational 1001 2-10 years Hip function, hip pain, loosening, acetabular erosion, reoperation rate 
30.  Ng et al. 40 2015 Observational 193 4 years 
Hip pain, hip function, acetabular erosion, component migration, 
revision surgery, rates of postoperative complications, satisfaction 
RCT: randomized clinical trial, LLD: limb length discrepancy, DVT: deep venous thrombosis, THR: total hip replacement, ROM: range of motion, ADL: activities of daily 
living 
 
 
Table 2: Demographic data of the studies groups 
Variable 
UH group BH group 
Observational studies RCTs Observational studies RCTs 
Number of patients 14182 878 14451 739 
Age, years (mean, range) 79.6 (55-85) 77.8 (55-85) 78.5 (55-85) 80.7 (55-85) 
Male/Female 5082/9100 270/608 4336/10115 289/450 
Delay in surgery, days 3.4 (2-9) 2.9 (2-9) 3.6 (2-9) 3.1 (2-9) 
Follow-up period, months 24.2 (6-72) 25.4 (6-72) 25.1 (6-72) 24.1 (6-72) 
UH: Unipolar hemiarthroplasty, BH: Bipolar hemiarthroplasty, RCTs: Randomized clinical trial 
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Hip pain data was available for eight studies (3 RCTs 17,19,25 and 5 observational studies 
4,24,32,36,39). The pooled risk ratio (figure 4a) showed no significant difference between the 
BH and UH groups in terms of postoperative hip pain (RR=0.90, 95% CI ]0.61, 1.33[, 
P=0.60). High heterogeneity was observed between these studies (I2=75%, P=0.0002), 
therefore, the random effect model was conducted. Sensitivity analysis was consistent with 
the previous analysis (figure 4b), and indicated no significant difference (RR=0.86, 95% 
CI]0.71, 1.05[, P=0.15), with low heterogeneity (I2=21%, P=0.27).  
Eight studies (3 RCTs 25,29,38 and 5 observational studies 2,26,27,31,34) contributed to the 
calculation of the summary estimate for reoperation rate. Under the fixed effect model, the 
pooled risk ratio (figure 5) favored the BH group over the UH group in terms of reoperation 
rate (RR=1.32, 95% CI ] 1.17, 1.50[, P<0.00001). No significant heterogeneity was 
observed (I2=18%, P=0.29). 
Four studies (2 RCTs 16,29 and 2 observational studies 22,32) reported operative time. The 
pooled mean difference (figure 6) showed significantly higher operative time with the BH 
group (MD=7.77 min, 95% CI ]4,00, 11.55[, P<0.0001). The studies were consistent in 
terms of statistical heterogeneity (I2=0%, P=0.46) and fixed effects model was conducted. 
The mean difference of intraoperative blood loss (figure 7) was pooled for four studies (2 
RCTs 16,29 and 2 observational studies 22,39) and showed no significant difference between 
the two compared groups (MD=24.00 ml, 95% CI ]-17.06, 65.06[, P=0.25). No substantial 
heterogeneity was observed (I2=24%, P=0.27). 
Four studies (1 RCT 29 and 3 observational studies 36,39,40) provided data on perioperative 
mortality. The pooled risk ratio (figure 8) showed no significant difference between the BH 
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and the UH groups in perioperative mortality (RR=1.17, 95% CI ]0.88, 1.56[, P=0.28). 
Pooled studies were homogenous (I2=0%, P=0.73). 
Four studies (2 RCTs 5,25 and 2 observational studies 21,34) provided data for mortality at 6 
months postoperatively. The pooled estimate did not favor either of the two groups 
(RR=1.00, 95% CI ]0.73, 1.35[, P=0.98). Pooled studies were homogenous (I2=0%, 
P=0.46). 
Eight studies (5 RCTs 5,17,25,28,38 and 3 observational studies 2,21,39) compared BH and UH 
in terms of mortality at one year follow up. The pooled estimate showed no significant 
difference between the BH and UH group for this parameter (RR=1.03, 95% CI ]0.87, 
1.22[, P=0.75). No evidence of heterogeneity was observed (I2=0%, P=0.85). 
Pooled estimates from four studies (2 RCTs 14,17 and 2 observational studies 20,27) did not 
favor either of BH or UH in terms of periprosthetic fractures (RR=0.58, 95% CI ]0.18, 
1.83[, P=0.35). Pooled studies were homogenous (I2=0%, P=0.9) (figure 9). 
Dislocations of prosthesis data was available for 19 studies (10 RCTs 5,14-19,25,29,38 and 9 
observational studies 20,26,27,32,34,36,37,39,40). The pooled RR (figure 9) revealed no significant 
difference between the two compared groups in terms of dislocation of prosthesis 
(RR=0.87, 95% CI ]0.59, 1.27[, P=0.47). No heterogeneity was observed among the pooled 
studies (I2=0%, P=0.73). Egger’s test showed no evidence of publication bias, P=0.42. 
Two observational studies reported data on loosening of prosthesis 24,27. The pooled 
estimate (figure 9) showed no significant difference between the two compared groups 
(RR=0.74, ]0.20, 2.82[, P=0.66), with no evidence of heterogeneity (I2=0%, P=0.85). 
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Wound infection data was provided by 13 studies (8 RCTs 5,14,16-18,25,28,38 and 5 
observational studies 20,24,34,36,40). The combined RR did not favor either of the two groups 
in terms of wound infection (RR=1.02, 95% CI ]0.61, 1.70[, P=0.94). No heterogeneity 
was observed among the pooled studies (I2=0%, 0.98) (figure 9). Egger’s test showed no 
evidence of publication bias, P=0.81. 
Two RCTs reported on quality of life. Inngual et al. 16 showed that the BH group has 
significantly higher quality of life over the UH group at 48 months’ follow up using EQ-
5D 16. Whilst, Raia et el. showed no significant difference between the two groups at one-
year follow up using SF-36 38. 
The total estimate from four studies (3 RCTs 18,19,35 and 2 observational studies 22,23) 
showed that the BH group was associated with better range of motion than the UH group 
(RR=2.48, 95% CI ]1.14, 3.82[, P=0.0003). Whilst subgroup analysis according to the type 
of motion showed no significant difference in flexion, abduction, adduction, external or 
internal rotation. High heterogeneity was observed so the random effect model was 
conducted (figure 10). 
The pooled RR from two RCTs 15,18 did not favor either of the two compared groups in 
terms of six-minute walk test (RR=-18.59, 95% CI ]-62.87, 25.70[, P=0.41). High 
heterogeneity was observed (I2=84%, P=0.01), therefore, the random effect model was 
conducted (figure 11). 
Seven studies (5 RCTs 5,16,19,25,33 and 2 observational studies 26,31) reported data on 
acetabular erosion. The pooled RR (figure 12) showed significantly higher acetabular 
erosion with the UH group compared to the BH group at four months’ follow-up (RR=0.32, 
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95% CI ]0.11, 0.93[, P=0.04), at one year (RR=0.23, ]0.06, 0.89[, P=0.03) and at two years 
(RR=0.39, 95% CI ]0.23, 0.67[, P=0.0006). At 4 years, however, there was no significant 
difference between the two compared groups (RR=0.54, 95% CI ]0.24, 1.20[, P=0.13). 
Five studies (3 RCTs 16,29,38 and 2 observational studies 34,40) reported on the number of 
patients who experienced pulmonary embolism postoperatively. The pooled RR (figure 13) 
did not favor either of the two groups in terms of pulmonary embolism (RR=0.92, 95% CI 
]0.38, 2.22[, P=0.85). There was no evidence of heterogeneity among pooled studies 
(I2=0%, P=0.95). 
Seven studies (3 RCTs 16,18,29 and 4 observational studies 20,22,34,40) reported the results of 
cardiac complications. The pooled estimate (figure 13) was comparable across the BH and 
UH groups (RR=0.75, 95% CI ]0.48, 1.16[, P=0.19). No heterogeneity was observed 
among these studies (I2=13%, P=0.33).  
The combined RR from five studies (3 RCTs 15,16,18 and 2 observational studies) showed 
no significant difference between the two compared groups in terms of deep venous 
thrombosis (RR=1.26, 95% CI ]0.54, 2.90[, P=0.59). The pooled studies were homogenous 
(I2=0%, P=0.82) (figure 13). 
Hospital stay data was reported by eight studies (5 RCTs 5,15,18,25,38 and 3 observational 
studies 22,32,39). The pooled mean difference (figure 14a) showed no significant difference 
between the BH and the UH groups in terms of hospital stay (MD=-1.34 days, 95% CI ]-
3.76, 1.07[, P=0.28). High heterogeneity was observed among pooled studies (I2=93%, 
P<0.00001), therefore, a random effect model was conducted. Further sensitivity analysis 
was performed after one observational study was excluded. The sensitivity analysis 
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revealed no significant difference (MD=0.14 days, 95% CI ]-0.45, 0.72[, P=0.64) with low 
heterogeneity (I2=5%, P=0.39) (figure 14b). 
Two RCTs 15,30 assessed the cost of the prostheses used and revealed that the bipolar 
implants were more expensive than the unipolar implants. 
Table 3: Outcomes of meta-analysis 
Outcomes Effect size (RR or MD) 95% CI P value Heterogeneity 
Postoperative hip function at 2 years 2.68 0.98 to 4.37 0.002 I2=0%, p=0.62 
Hip pain 0.90 0.61 to 1.33 0.60 I2=75%, P=0.0002 
Reoperation rate 1.32 1.17 to 1.50 P<0.00001 I2=18%, P=0.29 
Operative time 7.77 min 4,00 to 11.55 P<0.0001 I2=0%, P=0.46 
Intra-operative blood loss 24.00 ml -17.06 to 65.06 P=0.25 I2=24%, P=0.27 
Perioperative mortality 1.17 0.88 to 1.56 P=0.28 I2=0%, P=0.73 
Mortality at 6 months postoperative  1.00 0.73 to 1.35 P=0.98 I2=0%, P=0.46 
Mortality at 1 year postoperative 1.03 0.87 to 1.22 P=0.75 I2=0%, P=0.85 
Periprosthetic fractures 0.58 0.18 to 1.83 P=0.35 I2=0%, P=0.9 
Dislocations of prosthesis 0.87 0.59 to 1.27 P=0.47 I2=0%, P=0.73 
Loosening of prosthesis  0.74 0.20 to 2.82 P=0.66 I2=0%, P=0.85 
Wound infection 1.02 0.61 to 1.70 P=0.94 I2=0%, P=0.98 
Range of motion 2.48 1.14 to 3.82 P=0.0003 I2=96%, p<0.00001 
Six-minute walk -18.59 -62.87 to 25.70 P=0.41 I2=84%, P=0.01 
Acetabular erosion at 4m 0.32 0.11 to 0.93 P=0.04 I2=0%, P=0.80 
Acetabular erosion at 1 year 0.23 0.06 to 0.89 P=0.03 I2=0%, P=0.85 
Acetabular erosion at 2 years 0.39 0.23 to 0.67 P=0.0006 I2=0%, P=0.93 
Acetabular erosion at 4 years 0.54 0.24 to 1.20 P=0.13 I2=0%, P=0.70 
Pulmonary embolism 0.92 0.38 to 2.22 P=0.85 I2=0%, P=0.95 
Cardiac complications  0.75 0.48 to 1.16 P=0.19 I2=13%, P=0.33 
Deep venous thrombosis 1.26 0.54 to 2.90 P=0.59 I2=0%, P=0.82 
Hospital stay -0.39 -0.65 to -0.13 p=0.28 I2=93%, P<0.00001 
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Sensitivity analysis 
Sensitivity analysis was conducted to check for the effect of individual studies on the 
summary of effect size. None of the included studies could influence the summary effect 
estimates when removed from the analysis 6. Moreover, heterogeneity was resolved by 
performing sensitivity analysis. Consistency of the effect size, despite removal of the high 
risk of bias, confirms that the effect estimates obtained from our analysis are statistically 
robust.  the overall effect estimate did not change significantly for the outcomes hip pain 
and hospital stay  
DISCUSSION 
More than two thirds of all days spent in hospital for a fracture are owed to hip fractures 
41. The choice of treatment and outcome assessment in elderly patients is contentious 
because of their limited life expectancy. This makes early satisfaction as important as long-
term outcomes 5. With an annual mortality of 30% and associated substantial impairment 
of independence and quality of life, the treatment goal for hip fractures is to return to pre-
injury mobility status as early as possible 41,42.  
Treatment options for femoral neck fractures in elderly active patients include ORIF, 
hemiarthroplasty and total hip replacement. In a multicenter randomized controlled trial 
that compared all these methods of treatment, the authors concluded that arthroplasty is 
more clinically effective and cost-effective than reduction and fixation. Additionally, they 
supported the possibility of better long-term results with primary total hip replacement 43. 
Although some authors indicated better function with the total hip replacement 43,44, others 
stated no short-term significant differences between both modalities 45. Therefore, 
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hemiarthroplasty is still considered as the treatment of choice 46-48. Whether unipolar or 
bipolar hemiarthroplasty should be preferred is unknown. Several RCTs and observational 
studies comparing unipolar versus bipolar hemiarthroplasty reported on outcomes after hip 
hemiarthroplasty 2,4,5,14-29,31,32,34-41. There is no evidence supporting the choice between 
unipolar or bipolar femoral head prosthetic replacement. To rectify this, we pooled, in a 
meta-analysis, the results of 30 studies including 13 RCTs and 17 observational studies 
comparing unipolar and bipolar hemiarthroplasty in a total of 30250 patients 2,4,5,14-29,31,32,34-
41. 
The most important finding of our meta-analysis is that bipolar hemiarthroplasty provides 
better range of motion than unipolar hemiarthroplasty. Another main finding is that the 
reoperation rate and acetabular erosion are less frequent than with unipolar 
hemiarthroplasty. Although these results might favor implantation of bipolar 
hemiarthroplasty for femoral neck fractures in the elderly, data about quality of life in such 
patients is still missing. 
Several prospective, randomized studies have been published to compare functional 
outcomes of patients receiving either unipolar or bipolar hemiarthroplasty. Functional 
results in several of these studies observed similar results. Calder et al. published a 
prospective RCT comparing unipolar Thomson prosthesis with bipolar Monk prosthesis in 
patients over 80 years. At the 2-year follow-up interval the only statistically significant 
difference found was that patients with unipolar prostheses were more likely to return to 
their preinjury functional state than patients with bipolar prostheses 5. Davison et al. 
compared unipolar hemiarthroplasty, bipolar hemiarthroplasty and internal fixation with 
compression hip screws in patients between 65 and 79 years. They found no difference in 
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functional outcomes between unipolar and bipolar prostheses 25. Cornell et al. published a 
48-patient series in which the same femoral stem was used in all patients with the only 
difference being the prosthesis head design. Patients with bipolar prostheses did better on 
walking tests and had better range of motion at 6 months but the patient-oriented hip scores 
did not differ at 6 months between the unipolar and bipolar groups 15. Raia et al. compared 
the efficacy of unipolar versus bipolar hemiarthroplasty in elderly patients with displaced 
femoral neck fractures in terms of quality of life and functional outcomes. They found no 
difference between the groups when estimating blood loss, length of hospital stays, 
mortality rate, number of dislocations, postoperative complications or ambulatory status at 
1 year in their 115 patient series 38.  
Although it was not assessed in our analysis, the surgical approach may influence the 
postoperative hip range of motion and function. Several studies favored the anterolateral 
over the posterior approach as it preserves that posterior hip stabilizers and subsequently 
has a lower risk of dislocation than the posterior approach, a finding that matches previous 
studies 17,26,31,49. 
While several RCTs have failed to present convincing data on differences in clinical 
outcome between the unipolar and the bipolar designs, the overall pooled estimates of our 
meta-analysis provided better hip range of motion with the bipolar prosthesis. Therefore, 
in the active and independent elderly population, bipolar hemiarthroplasty might be the 
preferred option over unipolar hemiarthroplasty.  
The bipolar design has a theoretical advantage of less wear on acetabular cartilage. It has 
therefore been proposed as a more suitable alternative for more active patients with a longer 
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life expectancy 4,48. However, the polyethylene cover of the inner surface of the bipolar 
head may run the risk of polyethylene wear causing synovitis and loosening of the stem 26. 
Baker et al. introduced a grading system for acetabular erosion as judged from radiographs 
ranging from 0 (no erosion) to 3 (acetabular protrusion) 50. They reported acetabular 
erosion in an RCT after three years in 21 of 32 patients (66%) operated upon using a 
unipolar cemented HA. Thirteen of the 21 patients had only a grade 1 erosion. The same 
grading system was used in an RCT by Hedbeck et al. including 60 patients with Exeter 
bipolar HAs showing only 14% erosion (all grade 1) after four years 51. In another RCT by 
Enocson et al. of 120 patients allocated to treatment groups using either Exeter uni- or 
bipolar hemiarthroplasty the authors reported significantly less erosion in the bipolar (5%) 
group compared to the unipolar (20%) group after one year 26. Moreover, there was a trend 
towards worse hip function and a lower quality of life (EQ-5D) among patients with 
acetabular erosion compared to those without. Our pooled results confirm these findings as 
acetabular erosion was more frequent in the unipolar group. These results indicate that the 
bipolar design may be advantageous for patients with a long-life expectancy as predicted 
preoperatively by Carlson comorbidity index scoring system 52.  
Medical costs continue to increase and have been a subject of great interest over the past 
several years. The economic burden of caring for hip fracture patients is enormous and now 
contributes to a substantial percent of health care resources. The cost of caring for patients 
with hip fractures in the United States exceeds $8.7 billion; it is estimated that it will 
increase to more than $16 billion annually by 2040 53. Bipolar hemiarthroplasty is 
associated with longer operative time, although no significance in surgical or medical 
outcome was proved compared to unipolar HA. From an economical point of view, costs 
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may be higher with the bipolar hemiarthroplasty. However, given the difference in 
outcomes, bipolar hemiarthroplasty may be more cost-effective when considering the 
reoperation rate and hip function is superior. Unfortunately, evidence proving the cost 
effectiveness comparing both implant types is missing. 
The reoperation rate comparing uni- and bipolar prosthesis is controversial. Inngul et al. 
found no difference in reoperation rates between uni- and bipolar patients 16. This is in line 
with a previous study from the same institution on 830 Exeter HA patients with a median 
follow-up time of three years, where no difference in reoperation rate found between 
unipolar and bipolar HAs 26. In contrast, Leonardsson et al. reported significantly higher 
risk for reoperation in bipolar HAs compared to unipolar ones in patients from the Swedish 
hip arthroplasty register including all HAs performed in Sweden between 2005 and 2010 
31. The causes of reoperation in their study were dislocation, infection or periprosthetic 
fractures. A lower risk of reoperation due to acetabular erosion was shown in the bipolar 
than the unipolar hemiarthroplasty patients. Our pooled results are the opposite of these 
findings as the reoperation rate, dislocation, infection and periprosthetic fractures in bipolar 
HA were inferior compared to unipolar hip arthroplasty. An explanation could be that the 
risk of these complications generally increases in hemiarthroplasty procedures performed 
after failed internal fixation, in patients younger than 75 years and when uncemented stems 
were used or the posterior hip stabilizers were disturbed through a posterior hip approach 
17,31. 
Comparing the mortality of our pooled results, no difference was observed between both 
types of hemiarthroplasties. High mortality rates are directly proportionate to number of 
recurrent dislocations and preoperative comorbidities 26,54. 
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Limitations and strengths 
A comprehensive database search and a rigorous screening process permitted us to 
concentrate on the studies that suited our eligibility criteria and appropriate to the research 
question. A strength of our study was the large sample size (30,250 patients) so that data 
could be generalized. This is due to the inclusion of both observational studies and RCTs.  
Some of our results showed significant heterogeneity which was best resolved using 
subgroup and sensitivity analyses. The Cochrane Collaboration tool was utilized to assess 
the risk of bias of the included RCTs. For observational studies, the Newcastle Ottawa 
scale was applied. The results of this study are subjected to limitations inherent to any 
meta-analysis based on data pooling from different trials with heterogenous study protocol, 
definitions for efficacy and safety outcomes, and different baseline patient characteristic. 
Only published data were utilized. 
CONCLUSIONS 
Bipolar hemiarthroplasty is associated with longer operative time, greater range of motion 
and less acetabular erosion than unipolar hemiarthroplasty. However, no significant 
difference in hip function using Harris hip score, mortality, surgical, and medical outcomes 
is evident. Future large studies are recommended to compare both methods in terms of 
quality of life. 
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FIGURE LEGENDS 
Fig. 1. PRISMA Flow diagram of articles selection process 
Fig. 2. a. Risk of bias summary of randomized clinical trials, b. Risk of bias summary of 
observational studies 
Fig. 3. Forest plot of postoperative hip function 
Fig. 4. a. Forest plot of postoperative hip pain, b. Sensitivity analysis of hip pain 
Fig. 5. Forest plot of reoperation rate 
Fig. 6. Forest plot of operative duration 
Fig. 7. Forest plot of intra-operative blood loss 
Fig. 8. Forest plot of perioperative mortality and mortality at 6 months and one year after 
surgery 
Fig. 9. Forest plot of implant-related complications 
Fig. 10. Forest plot of postoperative hip range of motion 
Fig. 11. Forest plot of postoperative six-minute-walk test 
Fig. 12. Forest plot of postoperative acetabular erosion 
Fig. 13. Forest plot of postoperative medical outcomes 
Fig. 14. a. Forest plot of length of hospital stay, b. Sensitivity analysis of length of hospital 
stay 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies written in English, identified through PubMed (n=69), Scopus (n=77), Ebsco (n=33), 
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either uni- or bipolar hemiarthroplasty for intracapsular femoral neck fracture, with study 
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Figure 1. PRISMA (Preferred Reporting Items for Systematic of Reviews and Meta-
analyses) flow diagram of articles selection process. 
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